Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ResearchAndMarkets.compublished a new article on the Bio-Tech industry.
A number of British bio-tech companies reported disappointing returns recently, with a slump in stock prices and sluggish returns for recent innovations on the market.
London-based Syncona ended 2022 with net assets of £1.29 billion compared with £1.36 billionat the end of September, marking a 5.1 percent drop. London-based Autolus Therapeutics saw its stock almost halve in value from nearly $3 to $1.85 after announcing a$163.9 million fund-raising round in December. The round was initiated only hours after Autolus revealed its CD19 CAR-T cell therapy hit the end of a phase two trial in acute lymphoblastic leukemia, but the biotech’s pricing of the stock offering at $2 apiece may have dented the shares. Stevenage, England-based Freeline Therapeutics entered November with a share price around 75 cents but ended the year at just 47 cents.
Achilles Therapeutics’ shares hovered around the $2 mark in October and November before sinking to below 80 cents over December, which Syncona linked to a readout of the British biotech’s lead T cell program. Achilles claimed their data demonstrated a partial response and stable disease in heavily pre-treated patients with advanced non-small cell lung cancer, but investors were clearly unconvinced.
The article on ResearchAndMarkets.com contains a selection of reports on the Biotech industry such as:
The Directory of Biotech Startups in Japan 2021-2022
To see the full article and a list of related reports on the market, visit https://www.researchandmarkets.com/reports/5734572/bio-tech-uk-bio-tech-companies-struggle-sinking?utm_source=GNOM&utm_medium=PressRelease&utm_code=b7nxps&utm_campaign=1820082+-+Bio-tech+-+UK+Bio-Tech+Companies+Struggle+with+Sinking+Investment&utm_exec=como322prd-tech-uk-bio?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
